Overview
CI market data
Price History
CI price chart · 1M
- O
- 266.68
- H
- 273.36
- L
- 265.99
- C
- 272.16
- Vol
- 82,575.00
- Source
- US equities market feed
- Observed
- Cadence
- Five-minute page cache; daily and stored hourly bars
- Status
- fresh
Key Stats & Performance
- Open
- $266.68
- Previous Close
- $265.49
- Day High
- $273.36
- Day Low
- $265.99
- 52 Week High
- $303.39
- 52 Week Low
- $262.21
- 7 Day Return
- -1.13%
- 30 Day Return
- -2.54%
- 90 Day Return
- -1.81%
- 1 Year Return
- +0.37%
- Daily Notional Volume
- $22.5M Latest daily bar volume multiplied by its closing price.
Valuation & Profitability
- P/E (TTM)
- 10.98 Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- $22.18 Diluted earnings per share over the trailing twelve months.
- Beta
- 0.27 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- 1.7% Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- 2.3% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $239.51 – $315.47 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $70.5B · P/B 1.76 · P/S 0.25.
Company News
10 captured
Should You Buy, Hold or Sell CVS Stock Amid Consumer Wellness Growth?Zacks Investment Research ·
BTSG's Specialty Pharmacy Sales Up 30%: Will the Growth Continue?Zacks Investment Research ·
Bill Ackman Backs Mark Cuban's Drug Pricing Model: These Healthcare Stocks Could Win—Or LoseBenzinga ·
Can Cigna's Smart Coverage Help Close Health-Cost Gaps?Zacks Investment Research ·